These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9465091)
1. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Su Z; Goldstein NI; Fisher PB Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1764-9. PubMed ID: 9465091 [TBL] [Abstract][Full Text] [Related]
2. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Shen R; Su ZZ; Olsson CA; Fisher PB Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6778-82. PubMed ID: 7542776 [TBL] [Abstract][Full Text] [Related]
3. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. Sun Y; Lin J; Katz AE; Fisher PB Cancer Res; 1997 Jan; 57(1):18-23. PubMed ID: 8988032 [TBL] [Abstract][Full Text] [Related]
4. Translational infidelity and human cancer: role of the PTI-1 oncogene. Gopalkrishnan RV; Su ZZ; Goldstein NI; Fisher PB Int J Biochem Cell Biol; 1999 Jan; 31(1):151-62. PubMed ID: 10216950 [TBL] [Abstract][Full Text] [Related]
5. Transient reduction of PTI-1 expression by short interfering RNAs inhibits the growth of human prostate cancer cell lines. Yu L; Wu G; Wang L; Wang H; Zhang G Tohoku J Exp Med; 2006 Jun; 209(2):141-8. PubMed ID: 16707856 [TBL] [Abstract][Full Text] [Related]
6. Prostate-tumor-inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection. Scaggiante B; Bonin S; Cristiano L; Siracusano S; Stanta G; Dapas B; Giansante C; Fiotti N; Grassi G Cancer Invest; 2008 Oct; 26(8):800-8. PubMed ID: 18853312 [TBL] [Abstract][Full Text] [Related]
7. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection. Su ZZ; Olsson CA; Zimmer SG; Fisher PB Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547 [TBL] [Abstract][Full Text] [Related]
8. Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, form of translation elongatin factor 1A1, eEF1A1. Mansilla F; Hansen LL; Jakobsen H; Kjeldgaard NO; Clark BF; Knudsen CR Biochim Biophys Acta; 2005 Feb; 1727(2):116-24. PubMed ID: 15716006 [TBL] [Abstract][Full Text] [Related]
9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
10. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Sikes RA; Chung LW Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510 [TBL] [Abstract][Full Text] [Related]
11. PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells. Su Z; Shi Y; Friedman R; Qiao L; McKinstry R; Hinman D; Dent P; Fisher PB Nucleic Acids Res; 2001 Apr; 29(8):1661-71. PubMed ID: 11292838 [TBL] [Abstract][Full Text] [Related]
12. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Rinker-Schaeffer CW; Graff JR; De Benedetti A; Zimmer SG; Rhoads RE Int J Cancer; 1993 Nov; 55(5):841-7. PubMed ID: 8244582 [TBL] [Abstract][Full Text] [Related]
13. Reversion of human prostate tumorigenic growth by azatyrosine. Benoit RM; Eiseman J; Jacobs SC; Kyprianou N Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512 [TBL] [Abstract][Full Text] [Related]
14. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene. Ledwith BJ; Manam S; Kraynak AR; Nichols WW; Bradley MO Mol Cell Biol; 1990 Apr; 10(4):1545-55. PubMed ID: 1690847 [TBL] [Abstract][Full Text] [Related]
15. Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review). Boylan JF; Jackson J; Steiner MR; Shih TY; Duigou GJ; Roszman T; Fisher PB; Zimmer SG Anticancer Res; 1990; 10(3):717-24. PubMed ID: 2195986 [TBL] [Abstract][Full Text] [Related]
16. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013 [TBL] [Abstract][Full Text] [Related]
17. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103 [TBL] [Abstract][Full Text] [Related]